(.+-.)-p-Isobutylhydratropic acid | 21374 | CAPSULE;ORAL | EQ 200MG FREE ACID AND POTASSIUM SALT;30MG

p-Isobutylhydratropic acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

94 API Suppliers, 60 USDMF, 13 CEP/COS, 4 JDMF, 6 EU WC, 91 KDMF, 37 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

1118 FDF Dossiers, 318 FDA Orange Book, 332 Europe, 82 Canada, 15 Australia, 116 South Africa, 255 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 200MG, TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT, SUSPENSION;ORAL - 100MG/5ML, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT, TABLET;ORAL - 38MG;200MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, TABLET;ORAL - 200MG;10MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 19 DKSH, 2 Jai Radhe Sales, 3 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 12 Boai NKY Pharmaceuticals Ltd, 16 Gangwal Healthcare, 2 Kewpie Corporation, 15 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 4 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

131 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 58 Direct Compression, 50 Thickeners and Stabilizers, 44 Disintegrants & Superdisintegrants, 43 Solubilizers, 38 Controlled & Modified Release, 35 Parenteral, 35 Granulation, 34 Film Formers & Plasticizers, 34 Topical, 33 Taste Masking, 31 Lubricants & Glidants, 23 Co-Processed Excipients, 22 Chewable & Orodispersible Aids, 20 Emulsifying Agents, 13 API Stability Enhancers, 12 Rheology Modifiers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow, 173 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 262 Finished Drug Prices

MARKET PLACE

88 APIs, 38 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 8 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 27 Others

ANALYTICAL

2 BioAnalytical Methods, 1 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21374 / DOSAGE - CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
IBUPROFEN(UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM)	IBUPROFEN	200mg
PSEUDOEPHEDRINE HYDROCHLORIDE(UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F)	PSEUDOEPHEDRINE HYDROCHLORIDE	30mg

Inactive Ingredients

Ingredient Name	Haleon US Holdings LLC
D&C YELLOW NO. 10(35SW5USQ3G)
FD&C RED NO. 40(WZB9127XOA)
GELATIN, UNSPECIFIED(2G86QN327L)
MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POTASSIUM HYDROXIDE(WZH3C48M4T)
SORBITAN(6O92ICV9RU)
SORBITOL(506T60A25R)
WATER(059QF0KO0R)

Drug Product Composition: (.+-.)-p-Isobutylhydratropic acid